| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.04B | -9.5% | +6.4% |
| R&D Expense | $20.0M | +11.1% | +17.6% |
| SG&A Expense | $130.0M | -1.5% | +6.6% |
| Operating Income | $84.0M | -46.2% | -12.5% |
| Pre-tax Income | $33.0M | -57.1% | +26.9% |
| Income Tax | $11.0M | +237.5% | +10.0% |
| Net Income | $22.0M | -73.5% | +29.4% |
| EPS (Basic) | $0.30 | -73.5% | +30.4% |
| EPS (Diluted) | $0.29 | -73.4% | +26.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $433.0M | -5.0% | +23.0% |
| Accounts Receivable | $575.0M | +4.5% | -12.6% |
| Inventory | $366.0M | +7.0% | +2.8% |
| Current Assets | $1.81B | -0.5% | -6.3% |
| Total Assets | $5.64B | -0.5% | -1.7% |
| Current Liabilities | $1.85B | -2.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$9.0M | — | -107.3% |
| Capital Expenditures | $27.0M | — | -6.9% |
| Investing Cash Flow | -$25.0M | — | +32.4% |
| Financing Cash Flow | -$11.0M | — | +77.6% |
| Free Cash Flow | -$36.0M | — | -138.3% |
| -2.0% |
| Long-term Debt | $2.70B | +1.2% | -4.6% |
| Total Liabilities | $5.25B | -0.4% | -4.0% |
| Stockholders' Equity | $396.0M | -1.7% | +44.0% |